{"id":"NCT01035229","sponsor":"Novartis Pharmaceuticals","briefTitle":"Global Study Looking at the Combination of RAD001 Plus Best Supportive Care (BSC) and Placebo Plus BSC to Treat Patients With Advanced Hepatocellular Carcinoma.","officialTitle":"A Randomized Phase III, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Efficacy and Safety of Everolimus (RAD001) in Adult Patients With Advanced Hepatocellular Carcinoma After Failure of Sorafenib Treatment - The EVOLVE-1 Study","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-04","primaryCompletion":"2013-10","completion":"2013-10","firstPosted":"2009-12-18","resultsPosted":"2014-10-27","lastUpdate":"2016-09-22"},"enrollment":546,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Carcinoma"],"interventions":[{"type":"DRUG","name":"Everolimus","otherNames":["RAD001"]},{"type":"DRUG","name":"Everolimus Placebo","otherNames":[]},{"type":"OTHER","name":"Best Supportive Care (BSC)","otherNames":[]}],"arms":[{"label":"Everolimus + Best Supportice Care (BSC)","type":"EXPERIMENTAL"},{"label":"Placebo + Best Supportive Care","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to compare treatment with RAD001 plus best supportive care (BSC) to placebo plus BSC in patients with advanced HCC whose disease progressed while on or after sorafenib treatment or who are intolerant to sorafenib.","primaryOutcome":{"measure":"Overall Survival (OS)","timeFrame":"When 454 OS events were observed","effectByArm":[{"arm":"Everolimus + Best Supportive Care (BSC)","deltaMin":7.56,"sd":null},{"arm":"Placebo + Best Supportive Care","deltaMin":7.33,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":3},"locations":{"siteCount":131,"countries":["United States","Australia","Austria","Belgium","Canada","China","France","Germany","Greece","Hong Kong","Hungary","Israel","Italy","Japan","South Korea","Spain","Taiwan","Thailand"]},"refs":{"pmids":["27130844","25058218"],"seeAlso":["https://www.novartisclinicaltrials.com/TrialConnectWeb/home.nov"]},"adverseEventsSummary":{"seriousAny":{"events":171,"n":361},"commonTop":["Stomatitis","Decreased appetite","Oedema peripheral","Fatigue","Diarrhoea"]}}